With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.

Image Credit: Shutterstock.com

Produced by: Shazana Mokhtar

Presented by: Khoo Hsu Chuang, Philip See

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  vaccine,  intellectual property,  waiver,  pandemic,  Government/Regulatory/Policy Making,  Healthcare, Pharma, Biotech,  Economy, Markets